Metastatic Renal Cell Carcinoma Completed Phase 1 / 2 Trials for Everolimus (DB01590)
Also known as: Metastatic renal cell carcinoma (morphologic abnormality) / Metastatic renal cell carcinoma (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030098 (Metastatic Renal Cell Carcinoma) | Completed | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01136733 | A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment | Treatment |